Featured,Shroom News,Spotlight Stock Mind Cure Unveils Project to Treat Hypoactive Sexual Disorder Using MDMA-Assisted Psychotherapy By Dennis Mutua September 29, 2021 Mental health and wellness company focusing on development, manufacturing and distribution of organic functional mushroom products Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) unveiled a clinical research program focusing on u...
Psychedelic Stocks,Shroom News BetterLife Submits Patent Application For treatment of Cluster Headaches Using TD-0148A By Dennis Mutua September 28, 2021 Life sciences company focusing on developing next generation psychedelics medicines to treat unmet needs within mental health space BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) announced having submitted a patent application ...
Psychedelic Stocks,Shroom News Awakn Life Sciences Acquires Exclusive Rights to MDMA Study by Imperial College By Dennis Mutua September 24, 2021 Biotechnology company running clinical operations to research, develop and deliver psychedelics medicines to treat mental conditions and addictions Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) announced having acquired the...
Psychedelic Stocks,Shroom News Tryp Submits Application For Phase 2a Clinical Trials on Eating Disorders By Dennis Mutua September 23, 2021 Pharmaceutical company focused on identifying and developing clinical stage compounds for orphan diseases and unmet medical needs Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) says it has submitted an investigational new drug (IND)...
Shroom News,Spotlight Stock Small Pharma Completes Phase 1 Clinical Trial of DMT-Assisted Therapy By Dennis Mutua September 22, 2021 Neuropharmaceutical company focusing on developing rapid-active treatments for mental health conditions like anxiety and depression Small Pharma Inc. (TSVX: DMT) announced having successfully completed phase 1 clinical trial of DM...
Featured,Shroom News First Ever Actively Managed Psychedelics ETF Hits NYSE By Dennis Mutua September 21, 2021 At the end of last week, America based investment management company AdvisorShares launched the first ever United States actively managed psychedelic exchange-traded fund (ETF) dubbed AdvisorShares Psychedelics ETF (NYSE: PSIL) on...
Shroom News,Spotlight Stock Awakn Life Sciences to Acquire Norway Based Ketamine Psychotherapy Clinic By Dennis Mutua September 17, 2021 Biotechnology company running clinical operations to research, develop and deliver psychedelic therapies for mental conditions Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) announced having entered into an agreement to full...
Psychedelic Stocks,Shroom News Nova Mentis Submits FDA Application for Psilocybin Orphan Drug Designation By Dennis Mutua September 16, 2021 Life science company focusing on developing a psilocybin based therapeutics and complementary diagnostics for neuroinflammatory disorders Nova Mentis Life Science Corp. (CSE: NOVA) (OTCQB: NMSLF) announced having submitted an appl...